HTG Molecular Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- HTG Molecular Diagnostics's estimated annual revenue is currently $17.8M per year.
- HTG Molecular Diagnostics's estimated revenue per employee is $349,510
- HTG Molecular Diagnostics's total funding is $89M.
Employee Data
- HTG Molecular Diagnostics has 51 Employees.
- HTG Molecular Diagnostics grew their employee count by -39% last year.
HTG Molecular Diagnostics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 20% | N/A | N/A |
#3 | $1.7M | 11 | -45% | N/A | N/A |
#4 | $5.3M | 34 | 0% | N/A | N/A |
#5 | $4M | 26 | -7% | N/A | N/A |
#6 | $2.5M | 16 | 129% | N/A | N/A |
#7 | $1.4M | 9 | -25% | N/A | N/A |
#8 | $2.2M | 29 | 21% | $58.2M | N/A |
#9 | $177M | 1142 | -6% | N/A | N/A |
#10 | $0.9M | 6 | 200% | N/A | N/A |
What Is HTG Molecular Diagnostics?
HTG Molecular Diagnostics is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications. The Company's qNPAT molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based in Tucson, Arizona. Additional information is available at www.htgmolecular.com
keywords:Biotechnology$89M
Total Funding
51
Number of Employees
$17.8M
Revenue (est)
-39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
HTG Molecular Diagnostics News
HTG Molecular Diagnostics Inc is a commercial stage RNA platform-based life sciences company focused on advancing the promise of precision...
TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing...
HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2021 Results - Earnings Call Transcript. Mar. 29, 2022 9:29 PM ETHTG Molecular Diagnostics,...
HTG Molecular Diagnostics, a Tucson, Arizona-based provider of molecular technology solutions, has received a $500k investment from SR One, the corporate venture capital arm of GlaxoSmithKline, in the second tranche of its series D financing (read the news). The company, which has raised $16.2m ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.3M | 51 | -26% | N/A |
#2 | $9.4M | 51 | 9% | N/A |
#3 | $12.4M | 51 | -4% | N/A |
#4 | $7.5M | 51 | 4% | N/A |
#5 | $12.6M | 52 | 18% | N/A |